Direct acting antivirals for the treatment of chronic viral hepatitis

about

Lobohedleolide suppresses hepatitis C virus replication via JNK/c-Jun-C/EBP-mediated down-regulation of cyclooxygenase-2 expression.

P2860

Q54976857-2D007FDF-7889-4F6D-A39B-ED6870467D81

P2860

Direct acting antivirals for the treatment of chronic viral hepatitis

Item

http://www.wikidata.org/entity/Q27022216

description

2012 nî lūn-bûn

@nan

2012 թուականին հրատարակուած գիտական յօդուած

@hyw

2012 թվականին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

Direct acting antivirals for the treatment of chronic viral hepatitis

@ast

Direct acting antivirals for the treatment of chronic viral hepatitis

@en

Direct acting antivirals for the treatment of chronic viral hepatitis

@nl

type

Item

label

Direct acting antivirals for the treatment of chronic viral hepatitis

@ast

Direct acting antivirals for the treatment of chronic viral hepatitis

@en

Direct acting antivirals for the treatment of chronic viral hepatitis

@nl

prefLabel

Direct acting antivirals for the treatment of chronic viral hepatitis

@ast

Direct acting antivirals for the treatment of chronic viral hepatitis

@en

Direct acting antivirals for the treatment of chronic viral hepatitis

@nl

P1476

Direct acting antivirals for the treatment of chronic viral hepatitis

@en

P2093

Peter Karayiannis

http://www.w3.org/2001/XMLSchema#string

P2860

Binding of hepatitis C virus to CD81

HCV NS5A inhibits interferon-alpha signaling through suppression of STAT1 phosphorylation in hepatocyte-derived cell lines

The human scavenger receptor class B type I is a novel candidate receptor for the hepatitis C virus.

Recruitment and activation of a lipid kinase by hepatitis C virus NS5A is essential for integrity of the membranous replication compartment

Intramembrane proteolysis promotes trafficking of hepatitis C virus core protein to lipid droplets

RNA-templated replication of hepatitis delta virus: genomic and antigenomic RNAs associate with different nuclear bodies

Boceprevir for previously treated chronic HCV genotype 1 infection

Human hepatitis delta virus RNA subfragments contain an autocleavage activity

A single antigenomic open reading frame of the hepatitis delta virus encodes the epitope(s) of both hepatitis delta antigen polypeptides p24 delta and p27 delta

Mutational analysis of delta antigen: effect on assembly and replication of hepatitis delta virus

P304

478631

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.6064/2012/478631

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

2012

http://www.w3.org/2001/XMLSchema#string

P577

2012-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

258924274

http://www.w3.org/2001/XMLSchema#string

P698

24278700

http://www.w3.org/2001/XMLSchema#string

P932

3820491

http://www.w3.org/2001/XMLSchema#string

Direct acting antivirals for the treatment of chronic viral hepatitis

about

P2860

P2860

Direct acting antivirals for the treatment of chronic viral hepatitis

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P478

P577

P5875

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P478

P577

P5875

P698

P932